Artificial Intelligence for Drug Discovery
Landscape Overview Q1 2022

 

Full Report
Снимок экрана 2022-05-10 в 12.33.52.png
Снимок экрана 2022-05-10 в 12.35.05.png
Teaser
Снимок экрана 2022-05-10 в 12.37.03.png
One Pager

AI in Pharma Investment Digest Q4 2021

Investment Digest
image_2022-01-12_114711.png
Investment Digest
Teaser
image_2022-01-12_114931.png
Investment Digest
One Pager
Снимок экрана 2022-05-10 в 11.26.53.png

AI in Pharma Investment Digest Q3 2021

Investment Digest
image_2021-10-25_180708.png
Investment Digest
Teaser
image_2021-10-25_180831.png
Investment Digest
One Pager
image_2021-10-25_181057.png

AI in Pharma Investment Digest Q2 2021

Investment Digest
digest-pharm.png
Investment Digest
Teaser
pharma-digest.png
Investment Digest
One Pager
onepager.jpg

This Investment Digest summarizes key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI).

Here we have presented the information about key industry trends, 240 promising AI-driven biotech startups, and 50 leading biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors.